Literature DB >> 30746069

Design, synthesis, and biological activity of novel ammonium salts containing sterically hindered phenolic fragment and phosphoryl group.

Ramilya R Starodubtseva1, Elmira M Gibadullina1, Nurbala B Pazilova2, Anastasiia S Sapunova1, Alexandra D Voloshina1, Igor A Sudakov2, Alexandra B Vyshtakalyuk1, Michael A Pudovik1, Alexander R Burilov1, Sergey V Bukharov2.   

Abstract

Here, we present an approach to novel "hybrid" biologically active compounds based on a combination of sterically hindered phenol and ammonium pharmacophores in a single molecule. The novel target ammonium salts were obtained by the reaction of 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-N-(2-(dimethylamino)alkyl)propanamide with aliphatic bromides or by the reaction of phosphorylated methylenequinones with diamines followed by alkylation with organic bromides. A series of twenty-three novel multifunctional ammonium salts that contain a sterically hindered phenolic fragment were assessed for antimicrobial, cytotoxic and antioxidant activity. The compounds exhibited antimicrobial activity against Staphylococcus aureus ATCC 209p, Bacillus cereus ATCC 8035, Escherichia coli CDC F-50, Pseudomonas aeruginosa ATCC 9027, Aspergillus niger BKMF-1119, Trichophyton mentagrophytes var. gypseum 1773, and Candida albicans 855-653 in the concentration range of 442-0.70 μM. The maximum activity of an ammonium salt among all the types of structure was observed in cases in which a decyl radical was present on the onium nitrogen atom. The most active compounds exhibited antioxidant activity at levels of 0.25 and 0.50 mM and did not display cytotoxic properties towards WI-38 (human embryonic lung cells) and Chang liver (human liver cells) cell lines in the concentration range of 0.70-11.3 μM.

Entities:  

Year:  2018        PMID: 30746069      PMCID: PMC6335997          DOI: 10.1039/c8md00481a

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  15 in total

1.  The differential toxicity of ammonium salts.

Authors:  K S WARREN
Journal:  J Clin Invest       Date:  1958-04       Impact factor: 14.808

2.  Action of disinfectant quaternary ammonium compounds against Staphylococcus aureus.

Authors:  Christopher J Ioannou; Geoff W Hanlon; Stephen P Denyer
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

3.  Cationic lipids and surfactants as antifungal agents: mode of action.

Authors:  Débora B Vieira; Ana M Carmona-Ribeiro
Journal:  J Antimicrob Chemother       Date:  2006-08-02       Impact factor: 5.790

4.  Hydrophobic interactions are involved in the inhibition of human leukocyte elastase by alkyltrimethylammonium salts.

Authors:  A Kouadri-Boudjelthia; J M Wallach
Journal:  Int J Biochem Cell Biol       Date:  1997-02       Impact factor: 5.085

5.  Studies on the synthesis and anti-inflammatory activity of 2,6-di-tert-butylphenols with a heterocyclic group at the 4-position. I.

Authors:  Y Isomura; N Ito; H Homma; T Abe; K Kubo
Journal:  Chem Pharm Bull (Tokyo)       Date:  1983-09       Impact factor: 1.645

6.  Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate.

Authors:  F C Krebs; S R Miller; D Malamud; M K Howett; B Wigdahl
Journal:  Antiviral Res       Date:  1999-10       Impact factor: 5.970

7.  A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth.

Authors:  Vita M Golubovskaya; Carl Nyberg; Min Zheng; Frederick Kweh; Andrew Magis; David Ostrov; William G Cance
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

8.  In vitro activity of nonoxynol 9 on HeLa 229 cells and primary monkey cervical epithelial cells infected with Chlamydia trachomatis.

Authors:  D L Patton; S K Wang; C C Kuo
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

9.  Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF).

Authors:  M Steiner; R Landolfi; N C Motola; J G Turcotte
Journal:  Biochem Biophys Res Commun       Date:  1985-12-31       Impact factor: 3.575

Review 10.  Drug resistance in eukaryotic microorganisms.

Authors:  Alan H Fairlamb; Neil A R Gow; Keith R Matthews; Andrew P Waters
Journal:  Nat Microbiol       Date:  2016-06-24       Impact factor: 17.745

View more
  2 in total

1.  Quaternary Phosphonium Compounds: An Examination of Non-Nitrogenous Cationic Amphiphiles That Evade Disinfectant Resistance.

Authors:  Kyle J Sommers; Marina E Michaud; Cody E Hogue; Amber M Scharnow; Lauren E Amoo; Ashley A Petersen; Robert G Carden; Kevin P C Minbiole; William M Wuest
Journal:  ACS Infect Dis       Date:  2022-01-25       Impact factor: 5.084

2.  Metallocene QACs: The Incorporation of Ferrocene Moieties into monoQAC and bisQAC Structures.

Authors:  Kyle J Sommers; Brian S Bentley; Robert G Carden; Savannah J Post; Ryan A Allen; Renee C Kontos; Jacob W Black; William M Wuest; Kevin P C Minbiole
Journal:  ChemMedChem       Date:  2020-11-26       Impact factor: 3.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.